ERBB2 and cancer: In Project Achilles, both the GRB7 and ERBB2 composite Achilles scores showed a statistically signification association with GRB7 amplification (p = 0.001 and 0.0009, respectively, data not shown), indicating that GRB7 may be necessary for cancer cells harboring this amplicon, as previously suggested [25].